Vista Pharmaceuticals
Vista Pharmaceuticals Share Price Chart
Vista Pharmaceuticals last traded at ₹6.40 (2026-10-13). Over the past month the stock moved +10.2%, three months the stock moved -16.1%, year the stock moved -32.6%. Its closing range over 52 weeks is ₹5.70 – ₹9.94, with the latest close 35.6% below the high.
Closing prices up to 2026-10-13.
About Vista Pharmaceuticals
Incorporated in 1992, Vista Pharmaceuticals Ltd manufactures and sells pharmaceutical, medical and veterinary preparations[1]
Business Overview:[1][2] a) The company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories and veterinary preparations b) It manufactures pharmaceutical drugs such as sulphamethoxazole, trimethoprim and isoxsuprime. c) The company also sells its products to related companies (Common Directors) engaged in manufacturing formulations
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Vista Pharmaceuticals reported sales of ₹0.00 crore (-100.0%) and net profit of ₹-0.99 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.00 | -0.84 | – | -0.99 | -0.16 |
| Mar 2026 | 0.00 | -7.06 | – | -5.86 | -0.95 |
| Dec 2025 | 2.42 | -3.00 | -123.97 | -2.32 | -0.38 |
| Sep 2025 | 1.46 | -3.43 | -234.93 | -2.59 | -0.42 |
| Jun 2025 | 1.52 | -1.11 | -73.03 | -1.29 | -0.21 |
| Mar 2025 | 3.23 | -0.91 | -28.17 | -1.50 | -0.41 |
| Dec 2024 | 2.56 | -1.52 | -59.38 | -1.32 | -0.36 |
| Sep 2024 | 2.49 | -0.83 | -33.33 | -0.97 | -0.26 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -28.2% | +50.6% | +3.2% | -15.6% | -41.4% | -5.5% | -100.0% | -100.0% |
| Operating profit growth | – | – | -450.0% | – | – | – | – | – |
| Net profit growth | – | – | -1766.7% | – | – | – | – | – |
| EPS growth | – | – | -2150.0% | – | – | – | – | – |
| OPM % | -33.3% | -59.4% | -28.2% | -73.0% | -234.9% | -124.0% | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Vista Pharmaceuticals reported sales of ₹5.00 crore (-50.3%) and net profit of ₹-12.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 5.00 | -15.00 | -271.00 | -12.00 | -1.96 |
| Mar 2025 | 10.07 | -4.03 | -40.02 | -4.65 | -1.26 |
| Mar 2024 | 10.12 | -3.29 | -32.51 | -4.51 | -1.23 |
| Mar 2023 | 1.00 | -4.32 | -432.00 | -5.66 | -1.54 |
| Mar 2022 | 0.39 | -1.27 | -325.64 | -0.89 | -0.24 |
| Mar 2021 | 1.27 | -1.73 | -136.22 | -2.01 | -0.55 |
| Mar 2020 | 22.76 | -4.80 | -21.09 | -3.68 | -1.21 |
| Mar 2019 | 31.07 | 1.23 | 3.96 | 0.94 | 0.31 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +7.4% | -26.7% | -94.4% | -69.3% | +156.4% | +912.0% | -0.5% | -50.3% |
| Operating profit growth | -76.9% | -490.2% | – | – | – | – | – | – |
| Net profit growth | -57.1% | -491.5% | – | – | – | – | – | – |
| EPS growth | -58.7% | -490.3% | – | – | – | – | – | – |
| OPM % | 4.0% | -21.1% | -136.2% | -325.6% | -432.0% | -32.5% | -40.0% | -271.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Vista Pharmaceuticals.
Get Free AI Stock Analysis FREE →Latest News
-
Vista Pharmaceuticals accepts resignation of Company Secretary Barkha Jain - scanx.trade
Frequently Asked Questions
What is the share price of Vista Pharmaceuticals today?
Vista Pharmaceuticals shares were last quoted at ₹6.40 (+6.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Vista Pharmaceuticals?
Vista Pharmaceuticals has a price-to-earnings (P/E) ratio of -3.25 and a price-to-book (P/B) ratio of 1.08. The industry P/E is 53.33.
What is the 52-week high and low of Vista Pharmaceuticals?
The 52-week high of Vista Pharmaceuticals is ₹10.50 and the 52-week low is ₹5.32.
What is the market cap of Vista Pharmaceuticals?
The market capitalisation of Vista Pharmaceuticals is about ₹38.16 crore.
How did Vista Pharmaceuticals perform in its latest quarterly results?
In the latest quarter (Jun 2026), Vista Pharmaceuticals reported sales of ₹0.00 crore (-100.0%) and net profit of ₹-0.99 crore, compared with the same quarter last year.
Is Vista Pharmaceuticals a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Vista Pharmaceuticals has a 3-year ROE of -17.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Vista Pharmaceuticals?
Promoters hold about 21.19% of Vista Pharmaceuticals.
Which sector does Vista Pharmaceuticals belong to?
Vista Pharmaceuticals belongs to the Pharmaceuticals & Drugs sector.